Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Cancer Treatment Reports|April 1, 1982
Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study GroupR A Gams, J R Durant, A A BartolucciRadiology|November 1, 1977
The accuracy of retroperitoneal ultrasonography in Hodgkin's disease and non-Hodgkin's lymphomaD J Brascho, J R Durant, L E GreenCancer|December 11, 1975
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphomaJ R Durant, V Loeb, R Dorfman, et al.Journal of Biological Physics|January 25, 2013
Performance characteristics of a smith-purcell tunable terahertz sourceM Mross, T H Lowell, R Durant, et al.Scientific Reports|December 22, 2015
T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18RMichelle Goritzka, Catherine Pereira, Spyridon Makris, et al.Cancer|December 15, 1983
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's diseaseA A Bartolucci, C Liu, J R Durant, et al.Cancer Research|March 1, 1983
Tumor proliferation and chemotherapy in immunosuppressed miceV K Ghanta, K Shrestha, J R Durant, et al.Cancer|July 1, 1979
Unusual manifestations of non-Hodgkin's lymphomaA M Elisei, M J Norgard, J R Durant, et al.Cancer Treatment Reports|September 1, 1977
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphomaJ R Durant, R A Gams, A A Bartolucci, et al.Cancer|March 1, 1975
The pathologic behavior of primary vaginal carcinoma and its relationship to cervical cancerT M Murad, J R Durant, W A Maddox, et al.Pageof 5